Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

Name: Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A
Start: 2021-05-19T12:00:00-04:00
End: 2021-05-19T13:00:00-04:00

National May 19 12:00 pm to 1:00 pm EDT

Home
Events
Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

The presenters will discuss the history of psychedelics in therapeutic approaches with a primary focus on psilocybin. They will also review the neurobiology of psychedelics and the role of 5-HT2A receptors, review the results of recently published findings, and discuss the challenges associated with psychedelic-assisted therapies.

Jessie Chambers, PhD (OPDC)

Sr. Clinical & Scientific Liaison
Dennis Sholler, PhD (OPDC)

Clinical & Scientific Liaison
Amica Simmons-Yon, PharmD, PhD (OPDC)

Clinical & Scientific Liaison

Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

Related Events

Register

Related Events

Event Navigation

Now Leaving PsychU

This link will take you outside of the PsychU community website

Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

Featuring

Related Events

Virtual Event – Agitation Associated With Alzheimer’s Dementia Disease State Education: Disease State

Virtual Event – Agitation Associated with Alzheimer’s Dementia: Clinical, Humanistic, & Economic Burden

Register

Related Events

Virtual Event – Agitation Associated With Alzheimer’s Dementia Disease State Education: Disease State

Virtual Event – Agitation Associated with Alzheimer’s Dementia: Clinical, Humanistic, & Economic Burden

Event Navigation

Stay Connected: